Opinions of Healthcare Providers About Neuromodulation
1 other identifier
observational
91
1 country
1
Brief Summary
The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to healthcare providers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 4, 2021
CompletedFirst Posted
Study publicly available on registry
August 19, 2021
CompletedStudy Start
First participant enrolled
September 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 16, 2021
CompletedJanuary 11, 2022
January 1, 2022
14 days
August 4, 2021
January 10, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Physician goals, evaluated with a self-constructed question.
Goals of physicians to treat patients with neuromodulation for pain.
Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.
Physician expectations, evaluated with a self-constructed question.
Factors that respondents expect to change according to neuromodulation for pain.
Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.
Physician definition of success, evaluated with a self-constructed question.
Physician definition of success of neuromodulation for pain.
Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.
Study Arms (1)
Physicians using neuromodulation
Interventions
Physicians are asked to fill in an online survey regarding 1) goals to treat patients with neuromodulation for pain, 2) factors that respondents expect to change according to neuromodulation for pain and 3) their definition of success of neuromodulation for pain.
Eligibility Criteria
Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses).The survey will be spread at the 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris from 2/9/2021 to 4/9/2021.
You may qualify if:
- \- Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses).
You may not qualify if:
- \- Not involved in management of chronic pain through neuromodulation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Moens Maartenlead
Study Sites (1)
Vrije Universiteit Brussel
Brussels, 1090, Belgium
Related Publications (1)
Goudman L, De Smedt A, Billot M, Roulaud M, Rigoard P, Moens M. Opinions of Health Care Providers About Neuromodulation for Pain: Results of an Online Survey at the 2nd Joint Congress of the International Neuromodulation Society European Chapters. Neuromodulation. 2023 Dec;26(8):1887-1892. doi: 10.1016/j.neurom.2022.04.038. Epub 2022 May 10.
PMID: 35551866DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
August 4, 2021
First Posted
August 19, 2021
Study Start
September 2, 2021
Primary Completion
September 16, 2021
Study Completion
September 16, 2021
Last Updated
January 11, 2022
Record last verified: 2022-01